United States Biotechnology & Medical Research

Estrella Immunopharma Inc (ESLA)

Track

Track

Estrella Immunopharma Inc. recorded insider activity involving Chief Financial Officer Xu Jiandong, who executed three separate purchase transactions between September 11, 2025, and October 7, 2025. These acquisitions represent the most recent trading events for the firm, following a significant historical purchase by Co-CEO Li Jianwei in March 2022.
Ticker: ESLA Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.9
Xu Jiandong Chief Financial Officer Officer
Transaction date
Purchase
Price
320.03
Quantity 66,261 +9.7%
Value US$594,502
2.9
Xu Jiandong Chief Financial Officer Officer
Transaction date
Purchase
Price
106.35
Quantity 41,218 -10.2%
Value US$304,013
2.9
Xu Jiandong Chief Financial Officer Officer
Transaction date
Purchase
Price
492.68
Quantity 13,513 -10.0%
Value US$4,327,933
Li Jianwei Co-Chief Executive Officer Executive Director Large shareholder
Transaction date
Purchase
Price
314,700.00
Quantity 141,970 +12.8%
Value US$44,677,959,000
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-29 2025-10-07 B Purchase
2.9
Xu Jiandong

Chief Financial Officer

Officer
66,261 +9.7%
320.03
US$594,502 		66,261 +9.7% 320.03 US$594,502
2026-04-29 2025-09-22 B Purchase
2.9
Xu Jiandong

Chief Financial Officer

Officer
41,218 -10.2%
106.35
US$304,013 		41,218 -10.2% 106.35 US$304,013
2026-04-29 2025-09-11 B Purchase
2.9
Xu Jiandong

Chief Financial Officer

Officer
13,513 -10.0%
492.68
US$4,327,933 		13,513 -10.0% 492.68 US$4,327,933
2022-03-17 2022-03-04 B Purchase
Li Jianwei

Co-Chief Executive Officer

Executive Director Large shareholder
141,970 +12.8%
314,700.00
US$44,677,959,000 		141,970 +12.8% 314,700.00 US$44,677,959,000
Explore more

More insider trading research around Estrella Immunopharma Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America